Smith & Nephew
$40.319876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$40.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.49 (-1.20%) Today
$0.00 (0.00%) As of 7:20 AM EDT after-hours
Why Robinhood?
You can buy or sell Smith & Nephew and other stocks, options, ETFs, and crypto commission-free!
About SNN
Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. Read More The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.
Employees
17,637
Headquarters
Watford, Herefordshire
Founded
1937
Market Cap
17.62B
Price-Earnings Ratio
45.29
Dividend Yield
1.79
Average Volume
288.78K
High Today
$40.61
Low Today
$39.93
Open Price
$40.33
Volume
209.82K
52 Week High
$52.26
52 Week Low
$26.07
Collections
Analyst Ratings
58%
of 12 ratings
Buy
58%
Hold
25%
Sell
17%
SNN Earnings
$0.00
$0.25
$0.51
$0.76
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Jul 29, Pre-Market